Pfizer Expands Commitment to Creating a “Healthier World”

Pfizer has significantly expanded its commitment to “An Accord for a Healthier World” to bring its full portfolio of medicines and vaccines for which it has global rights on a not-for-profit basis to an estimated 1.2 billion people.

In order to address unmet patient needs in the 45 lower-income countries covered by the Accord, Pfizer will increase the number of products to now include off-patent medicines. The expansion brings the total offering from 23 to approximately 500 products. As Pfizer launches new medicines and vaccines, those products will also be included in the Accord portfolio on a not-for-profit basis.

Pfizer continues to make a broader impact around the world. The Accord is a testament to the company’s longstanding commitment of creating a healthier world.

Learn more about the “Accord for a Healthier World”

Helping to Close the Health Equity Gap

“We launched the Accord to help reduce the glaring health equity gap that exists in our world,” said Pfizer Chairman and CEO Albert Bourla. “We believe this expansion of our product offering, combined with continued efforts to help address the barriers that limit or prevent access, will help us to achieve and even expedite our vision of a world where all people have access to the medicines and vaccines they need to live longer and healthier lives.”

The Accord, which was launched in May 2022, now includes medicines and vaccines that treat or prevent many of the greatest infectious and non-communicable disease threats faced today in lower-income countries. This includes chemotherapies and oral cancer treatments that have the potential to treat nearly one million new cancer cases in Accord countries each year.

The initiative is already making an impact.

To date, Pfizer has delivered nine medicines and vaccines to Rwanda for the treatment of certain cancers, infectious and inflammatory diseases. The company is also collaborating with the Rwandan Ministry of Health to provide healthcare education training to support the delivery.

The company is also working with the Ministries of Health in Malawi, Ghana and Senegal as well as a number of other Accord countries to better understand the critical healthcare needs and opportunities for health system strengthening.

Countries in ‘An Accord for a Healthier World’

*Supply contingent upon complicance with applicable laws including any required sanctions and export conrol licenses or other authorizations.

Join Pfizer Investor Insights

Sign up to receive important updates about Pfizer, how we’re innovating for patients and delivering value for shareholders. Email updates will also provide exciting opportunities for individual shareholders to hear from our leadership and experts.

I would like to receive information, updates, and hear from leadership regarding Pfizer Investor Insights and other investor relations initiatives in accordance with Pfizer’s Privacy Policy.